NewBiotics Inc. Appoints New President

Article

SAN DIEGO, Calif-NewBiotics, Inc announced January 8, that H. Michael Shepard, will be the company's president.

Shepard will be responsible for overseeing all aspects of the company's research and development strategies, scientific and corporate collaborations, and related activities.

NewBiotics, a developer of drugs targeted against cancer and infectious disease, is privately held. The company's drugs use a "Trojan horse solution" to fight various diseases.

Shepard, who previously worked for Canji, and Genentech, helped develop the p53gene product for cancer therapy.

Related Videos
Patient Safety: Infection Control Today's Trending Topic for March
Infection Control Today® (ICT®) talks with John Kimsey, vice president of processing optimization and customer success for Steris.
Picture at AORN’s International Surgical Conference & Expo 2024
Infection Control Today and Contagion are collaborating for Rare Disease Month.
Rare Disease Month: An Infection Control Today® and Contagion® collaboration.
Vaccine conspiracy theory vector illustration word cloud  (Adobe Stock 460719898 by Colored Lights)
Rare Disease Month: An Infection Control Today® and Contagion® collaboration.
Infection Control Today Topic of the Month: Mental Health
Infection Control Today's topic of the month: Mental Health
Related Content